Highlights
NASDAQ: ENDP       Endo Int'l Plc
Last Price Today's Change   Day's Range   Trading Volume
5.92   -0.675 (10.24%)  5.87 - 6.66  10,880,000

Overview

 
Avg Volume (4 weeks):7,646,233
4 Weeks Range:4.28 - 6.73
4 Weeks Price Volatility (%):
66.94%
52 Weeks Range:1.97 - 12.49
52 Weeks Price Volatility (%):
37.55%
Average Price Target: 75.00
Price Target Upside/Downside: +69.08

Headlines



No recent Headlines for this stock.


Business Background

Endo International PLC, formerly Endo Health Solutions Inc., is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm , Opana ER, Voltaren Gel, Percocet , Frova , Supprelin LA, Vantas , Valstar and Fortesta Gel. The Company operates in three segments: Endo Pharmaceuticals, Qualitest and AMS. In April 2014, the Company acquired worldwide rights to Sumavel DosePro (sumatriptan injection) for subcutaneous use, a needle-free delivery system for sumatriptan, from Zogenix, Inc. In July 2014, it acquired Grupo Farmaceutico Somar. In August 2014, Endo International PLC acquired DAVA Pharmaceuticals, Inc., a privately-held company specializing in generic pharmaceuticals.

  Be the first to like this.
 


 

1843  6298  540  225 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers